Beam Therapeutics BEAM
NASDAQ BEAM
$24.98 -0.83 (-3.22%)
As of: Nov 12, 2026 · 12:03 PM EST

Beam Therapeutics (BEAM) Interest & Investment Income (2019 - 2026)

Updated

Beam Therapeutics (BEAM) posted Interest & Investment Income of $6.09 million for Q3 2026, down 44.1% from $10.9 million a year earlier and down 18.6% from the prior quarter.

Analysis

Beam Therapeutics (BEAM) Interest & Investment Income (2019 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Interest & Investment Income at Beam Therapeutics was $34.09 million, down 22.6% year-over-year; for FY2025, it was $43.73 million, down 10.9% from FY2024.

  • Annual Interest & Investment Income shows a five-year compound annual growth rate of 110.8% (FY2020 to FY2025).
  • In prior years, Beam Therapeutics' Interest & Investment Income was $49.09 million in FY2024 (+5.2%), $46.68 million in FY2023 (+205.1%), $15.3 million in FY2022 and -$9,000 in FY2021.
  • The Q3 2026 figure stands as the lowest quarterly Interest & Investment Income since Q3 2022.
  • The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q2 2023, with growth of 480.2%; the weakest was Q3 2026, with a decline of 44.1%.
  • According to Business Quant data, Interest & Investment Income for the three prior quarters was $7.49 million (Q2 2026), $9.87 million (Q1 2026) and $10.64 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 186.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 67.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Beam Therapeutics 2.60 Bn -2.05 Bn - 6.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 6.09 Mn
Jun 30, 2026 7.49 Mn
Mar 31, 2026 9.87 Mn
Dec 31, 2025 10.64 Mn
Sep 30, 2025 10.90 Mn
Jun 30, 2025 12.33 Mn
Mar 31, 2025 9.86 Mn
Dec 31, 2024 10.93 Mn
Sep 30, 2024 12.13 Mn
Jun 30, 2024 14.19 Mn
Mar 31, 2024 11.85 Mn
Dec 31, 2023 12.06 Mn
Sep 30, 2023 12.70 Mn
Jun 30, 2023 11.95 Mn
Mar 31, 2023 9.96 Mn
Dec 31, 2022 7.61 Mn
Sep 30, 2022 4.98 Mn
Jun 30, 2022 2.06 Mn
Mar 31, 2022 644,000.00
Dec 31, 2021 54,000.00
API Access

Beam Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=BEAM&period=max&api_key=YOUR_API_KEY